Literature DB >> 8626240

Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity.

R B Lingham1, A H Hsu, J A O'Brien, J M Sigmund, M Sanchez, M M Gagliardi, B K Heimbuch, O Genilloud, I Martin, M T Diez, C F Hirsch, D L Zink, J M Liesch, G E Koch, S E Gartner, G M Garrity, N N Tsou, G M Salituro.   

Abstract

Quinoxapeptin A and B are novel chromodepsipeptides which were isolated from a nocardioform actinomycete with indeterminant morphology. Quinoxapeptins A and B are potent inhibitors of HIV-1 and HIV-2 reverse transcriptase and almost equally active against two single mutants forms as well as a double mutant form of HIV-1 reverse transcriptase. Quinoxapeptin A and B are specific inhibitors of HIV-1 and HIV-2 reverse transcriptase because they did not inhibit human DNA polymerase alpha, beta, gamma and delta. Quinoxapeptin A and B are structurally similar to luzopeptin A which was also active against HIV-1 and HIV-2 reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626240     DOI: 10.7164/antibiotics.49.253

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Highly efficient synthesis of quinoxaline derivatives from 1,2-benzenediamine and α-aminoxylated 1,3-dicarbonyl compounds.

Authors:  Jianwei Yan; Yanhong Xu; Fangfang Zhuang; Jie Tian; Guisheng Zhang
Journal:  Mol Divers       Date:  2016-01-21       Impact factor: 2.943

2.  Rationally engineered total biosynthesis of a synthetic analogue of a natural quinomycin depsipeptide in Escherichia coli.

Authors:  Kenji Watanabe; Kinya Hotta; Alex P Praseuth; Mark Searcey; Clay C C Wang; Hiroki Oguri; Hideaki Oikawa
Journal:  Chembiochem       Date:  2009-08-17       Impact factor: 3.164

3.  Identification and characterization of the biosynthetic gene cluster of polyoxypeptin A, a potent apoptosis inducer.

Authors:  Yanhua Du; Yemin Wang; Tingting Huang; Meifeng Tao; Zixin Deng; Shuangjun Lin
Journal:  BMC Microbiol       Date:  2014-02-08       Impact factor: 3.605

Review 4.  Recent advances in the transition-metal-free synthesis of quinoxalines.

Authors:  Biplob Borah; L Raju Chowhan
Journal:  RSC Adv       Date:  2021-11-19       Impact factor: 4.036

Review 5.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.